Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Cancer Cell

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    October 2016
  1. SHAN L, Zhou X, Liu X, Wang Y, et al
    FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis.
    Cancer Cell. 2016 Oct 14. pii: S1535-6108(16)30445.
    PubMed     Text format     Abstract available


    September 2016
  2. ZENG H, Qu J, Jin N, Xu J, et al
    Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.
    Cancer Cell. 2016;30:459-73.
    PubMed     Text format     Abstract available


    March 2016
  3. HARICHARAN S, Lei J, Ellis M
    Mammary Ductal Environment Is Necessary for Faithful Maintenance of Estrogen Signaling in ER(+) Breast Cancer.
    Cancer Cell. 2016;29:249-50.
    PubMed     Text format     Abstract available


  4. MALUMBRES M
    CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2(+) Breast Cancer.
    Cancer Cell. 2016;29:243-4.
    PubMed     Text format     Abstract available


  5. HALBERG N, Sengelaub CA, Navrazhina K, Molina H, et al
    PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion.
    Cancer Cell. 2016;29:339-53.
    PubMed     Text format     Abstract available


  6. JING H, Hu J, He B, Negron Abril YL, et al
    A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.
    Cancer Cell. 2016;29:297-310.
    PubMed     Text format     Abstract available


  7. GOEL S, Wang Q, Watt AC, Tolaney SM, et al
    Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.
    Cancer Cell. 2016;29:255-69.
    PubMed     Text format     Abstract available


  8. SFLOMOS G, Dormoy V, Metsalu T, Jeitziner R, et al
    A Preclinical Model for ERalpha-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response.
    Cancer Cell. 2016 Mar 1. pii: S1535-6108(16)30036.
    PubMed     Text format     Abstract available


    January 2016
  9. LI JY, Perry SR, Muniz-Medina V, Wang X, et al
    A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
    Cancer Cell. 2016;29:117-29.
    PubMed     Text format     Abstract available


    December 2015
  10. VON EYSS B, Jaenicke LA, Kortlever RM, Royla N, et al
    A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer.
    Cancer Cell. 2015;28:743-57.
    PubMed     Text format     Abstract available


    October 2015
  11. STINE ZE, Dang CV
    Splicing and Dicing MYC-Mediated Synthetic Lethality.
    Cancer Cell. 2015;28:405-6.
    PubMed     Text format     Abstract available


    August 2015
  12. PARKER JS, Perou CM
    Tumor Heterogeneity: Focus on the Leaves, the Trees, or the Forest?
    Cancer Cell. 2015;28:149-50.
    PubMed     Text format     Abstract available


  13. TOKER A, Rameh L
    PIPPing on AKT1: How Many Phosphatases Does It Take to Turn off PI3K?
    Cancer Cell. 2015;28:143-5.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: